Shares of Informa plc (LON:INF - Get Free Report) have received a consensus rating of "Buy" from the six research firms that are covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have covered the stock in the last year is GBX 1,135.
INF has been the topic of a number of research reports. JPMorgan Chase & Co. decreased their target price on shares of Informa from GBX 1,300 to GBX 1,285 and set an "overweight" rating on the stock in a research note on Thursday, July 2nd. Berenberg Bank upped their price target on Informa from GBX 965 to GBX 1,040 and gave the company a "buy" rating in a research report on Friday, July 31st. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a GBX 1,140 price target on shares of Informa in a report on Friday, July 31st. Finally, Citigroup lifted their price objective on Informa from GBX 990 to GBX 1,090 and gave the stock a "buy" rating in a research report on Wednesday, August 12th.
Read Our Latest Analysis on Informa
Informa Price Performance
Informa stock opened at GBX 874.60 on Friday. Informa has a 52-week low of GBX 719 and a 52-week high of GBX 1,000. The firm has a market capitalization of £10.93 billion, a price-to-earnings ratio of 51.15, a PEG ratio of 0.75 and a beta of 0.68. The company has a fifty day simple moving average of GBX 895.75 and a 200-day simple moving average of GBX 842. The company has a quick ratio of 1.70, a current ratio of 0.55 and a debt-to-equity ratio of 64.99.
Informa (LON:INF - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The company reported GBX 26.70 earnings per share for the quarter. Informa had a net margin of 5.43% and a return on equity of 3.90%. On average, equities analysts anticipate that Informa will post 59.3240265 EPS for the current fiscal year.
About Informa
(
Get Free Report)
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Informa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Informa wasn't on the list.
While Informa currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.